NSCLC Subtype Prediction Using Cytologic Fluid Specimens From Needle Aspiration Biopsies

作者: Arthur Cho , Jin Hur , Yoo Jin Hong , Hye-Jeong Lee , Young Jin Kim

DOI: 10.1309/AJCPYOJYG56UNBSZ

关键词: Cystic fibrosisTumor markerPathologyBiopsyCarcinoembryonic antigenSurvival rateMedicineProspective cohort studyAdenocarcinomaLung cancer

摘要: This study evaluated the diagnostic usefulness of tumor marker concentrations in cytologic fluids (CF) for subtyping non–small cell lung cancer (NSCLC) and assessed relationship between fluorine-18fluorodeoxyglucose ( 18 F-FDG) uptake with serum CF levels. prospective included 88 patients diagnosed adenocarcinoma or squamous carcinoma (SCC). Cytokeratin-19 fragment (CYFRA 21-1), carcinoembryonic antigen (CEA), (SCCA) samples were correlated concentrations, F-FDG uptake, NSCLC subtype. Fifty-eight adenocarcinoma. Multivariate analysis revealed higher SCCA levels; smoking status predicted SCC from showed highest accuracy (83%) distinguishing obtained during routine needle aspiration biopsy procedure contain levels sufficient to distinguish adenocarcinoma; had accuracy. Lung cancer, leading cause death worldwide, has a 5-year survival rate less than 15%. However, recently developed chemotherapeutic agents molecular targeting have significantly improved prognosis nonsquamous (NSCLC). 1-5 Accordingly, accurate subclassification these

参考文章(36)
Giovanni Selvaggi, Giorgio V Scagliotti, Histologic Subtype in NSCLC: Does It Matter? Oncology. ,vol. 23, pp. 1133- 1140 ,(2009)
A Aydiner, E Topuz, P Saip, F Tas, V Yasasever, A Karadeniz, Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer. Journal of Experimental & Clinical Cancer Research. ,vol. 19, pp. 477- 481 ,(2000)
Amanda Tufman, Rudolph Maria Huber, None, Biological markers in lung cancer: A clinician's perspective. Cancer Biomarkers. ,vol. 6, pp. 123- 135 ,(2010) , 10.3233/CBM-2009-0124
Jan Kulpa, Ewa Wójcik, Marian Reinfuss, Leszek Kołodziejski, Carcinoembryonic Antigen, Squamous Cell Carcinoma Antigen, CYFRA 21-1, and Neuron-specific Enolase in Squamous Cell Lung Cancer Patients Clinical Chemistry. ,vol. 48, pp. 1931- 1937 ,(2002) , 10.1093/CLINCHEM/48.11.1931
Keiichiro Nakamura, Yoshihiro Okumura, Junichi Kodama, Atsushi Hongo, Susumu Kanazawa, Yuji Hiramatsu, The predictive value of measurement of SUVmax and SCC-antigen in patients with pretreatment of primary squamous cell carcinoma of cervix Gynecologic Oncology. ,vol. 119, pp. 81- 86 ,(2010) , 10.1016/J.YGYNO.2010.04.020
Corey J. Langer, Benjamin Besse, Antonio Gualberto, Elizabeth Brambilla, Jean-Charles Soria, The Evolving Role of Histology in the Management of Advanced Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 28, pp. 5311- 5320 ,(2010) , 10.1200/JCO.2010.28.8126
Marianne Paesmans, Thierry Berghmans, Michele Dusart, Camillo Garcia, Claude Hossein-Foucher, Jean-Jacques Lafitte, Céline Mascaux, Anne-Pascale Meert, Martine Roelandts, Arnaud Scherpereel, Vanessa Terrones Munoz, Jean-Paul Sculier, Primary Tumor Standardized Uptake Value Measured on Fluorodeoxyglucose Positron Emission Tomography Is of Prognostic Value for Survival in Non-small Cell Lung Cancer: Update of a Systematic Review and Meta-Analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project Journal of Thoracic Oncology. ,vol. 5, pp. 612- 619 ,(2010) , 10.1097/JTO.0B013E3181D0A4F5
F Walker, R A Burnett, S R Howatson, S Lang, F D Lee, A M Lessells, K M McLaren, E R Nairn, S Ogston, A J Robertson, J G Simpson, G D Smith, H B Tavadia, Observer variability in histopathological reporting of non-small cell lung carcinoma on bronchial biopsy specimens. Journal of Clinical Pathology. ,vol. 49, pp. 130- 133 ,(1996) , 10.1136/JCP.49.2.130
Ross C. Brownson, Jian C. Chang, James R. Davis, Gender and histologic type variations in smoking-related risk of lung cancer. Epidemiology. ,vol. 3, pp. 61- 64 ,(1992) , 10.1097/00001648-199201000-00012